Skip to main content

Larimar Therapeutics, Inc.

LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001374690

In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Larimar Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of LRMR: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders5745−12
Shares14.1M14.5M+433.6K (+3.1%)
Value$206.1M$142.8M−$63.3M (−30.7%)

New holders (8)

Institutions that held Larimar Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to LRMR in Q2 2021
InstitutionSharesValue% of portfolio
Opaleye Management Inc.727,800$7.15M1.19%
Ghost Tree Capital, LLC100,000$982.0K0.31%
Adage Capital Partners GP, L.L.C.76,680$753.0K0.00%
State Street Corp39,033$383.0K0.00%
Goldman Sachs Group Inc14,314$141.0K0.00%
Acadian Asset Management LLC457$4.00K0.00%
Simplex Trading, LLC157$1.00K0.00%
Disciplined Investments, LLC116$1.00K0.00%

Sold out (20)

Institutions that held Larimar Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.